Loans4Less.com, an online mortgage loan origination company, is shifting its focus towards becoming a national loan origination brand platform for conforming residential mortgage programs and other consumer loans. Through the recently announced acquisition of 321LEND, Inc., the company is in a strong position to build volume and rapidly gain market share in both the mortgage and consumer loan sectors. As Loans4Less continues to search for a strategic community bank partner to launch a national mortgage program and increase brand awareness, the domestic economy appears to be shifting in the company’s favor moving forward.

¬According to a report by the Mortgage Bankers Association, mortgage origination has been on the rise since 2010, with the first quarter of 2015 posting the highest first quarter origination figures in nearly a decade. These statistics directly correlate with the national unemployment rate. According to the Bureau of Labor Statistics, the unemployment rate for April 2015 was the lowest since 2008. Continued improvement to the national economy is a positive indicator for Loans4Less, particularly as executives look to increase its national presence.

Since its formation in 1993, Loans4Less has maintained a steady order flow from a large client base. The company’s high business volume and impeccable reputation allowed it to survive the financial crisis of 2007, and its strong brand makes it a promising player in the industry.

“Loans are a product and service that people every day of the week across the country are looking for,” stated Steven M. Hershman, President and Chairman of the Board at Loans4Less. “It is such a huge and ongoing business that we think we can make an impact.”

Loans4Less has continued to thrive while many of its competitors have faded away by adhering to a safe, effective business strategy. The company does not operate a warehouse line of credit, hold trust funds, service loans or lend directly. Therefore, Loans4Less avoids many of the risks associated with Sub-Prime lending, making the company a relatively safe choice for investors. As the company continues to grow revenue through cost effective advertising efforts and strategic national partnerships, look for Loans4Less to continue expanding its share of the national loan origination market.

For more information, visit www.Loans4Less.com

Let us hear your thoughts: Loans4Less.com, Inc. Message Board

Until recently, rice bran and germ remained an underutilized byproduct of the commercial rice-milling industry. In the early 1990s, however, a group of innovators developed new technology to process this byproduct into nutritional food that features nearly limitless possibilities as a healthy ingredient. RiceBran Technologies (NASDAQ: RIBT), through the dedication of its employees and strategic partners, is rapidly becoming one of the world’s leading suppliers of rice bran, effectively unlocking entry into a variety of vital and potentially lucrative markets around the globe.

RIBT currently operates an expansive network of production facilities around the United States and abroad. In Louisiana and California, the company operates three Stage One facilities, which process bran and germ as soon as it is removed from the kernel to deactivate the enzymes that cause rancidity in the product. In Montana, the company’s Stage Two facility processes, dries and packages the product for sale to food manufacturers and retail consumers. RIBT’s primary distribution facility is located in Texas. The company also operates a rice bran oil production facility in Brazil.

Unlike other forms of bran, the company’s rice bran and related byproducts are particularly marketable because they are nutrient rich, contain no major allergens and are free from cholesterol, gluten, lactose and trans fat. This versatility has allowed RIBT to establish a presence in multiple food industries as an ingredient, a meat emulsifier, a cooking oil and, even, a high-end feed for equine athletes and pets.

In the first quarter of 2015, RIBT turned its attention towards improving returns for investors and shareholders. In addition to a slight increase in gross margins from the previous year at its domestic production facilities, the company realized a 70.8 percent rise in segment revenue in Brazil as a result of increased production. Likewise, consolidated revenue saw a 25.7 percent spike from the previous year, giving potential investors strong incentive to consider this growing company.

“[W]e enter 2015 focused on improving financial performance,” stated W. John Short, Chief Executive Officer and President of RIBT. “As we move through 2015, we intend to work diligently to maximize both our top and bottom line financial performance to reach our goal of positive EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization) in 2015.”

RIBT has established its position as a unique provider of healthy whole food nutrition products in recent years, and it appears to be on the cusp of substantial growth opportunities moving forward. With significant improvement projects at the company’s production facilities largely completed, RIBT’s renewed focus on financial performance should open the door for improved shareholder returns in the coming years.

For more information, visit www.ricebrantech.com

Approximately 150 billion cubic meters of natural gas are flared into the atmosphere each year, resulting in billions in lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions. Even worse, environmental degradation associated with gas flaring significantly impacts local populations to the point of loss of livelihood and severe health issues. Under pressure by Environmental Protection Agency mandates to reduce wasted gas, many oil companies are scrambling for a solution.

Houston-based Well Power sees this great energy challenge as an opportunity to provide a much-needed solution while creating value from a wasted resource. In turn, this solution would enable wider access to energy, improve environmental conditions, and foster economic development for local populations.

Well Power has licensing rights to Texas, with the first right of refusal on the other U.S. states, to patented technology called the Micro-Refinery Unit (MRU), which is capable of processing waste natural gas – such as vented, flared or stranded gas – into green fuel and clean power. The technology is also mobile and scalable, meaning it can be transported and adapted to site conditions.

If you want to get technical, here’s how it works: with the ability to process raw natural gas flows of between 75 Mcf to 250 Mcf, the MRU first conditions and then converts methane and condensates to Syngas (CO and hydrogen). This is followed by a Fischer-Tropsch reaction to produce Green Fuel™, and power which is produced from heat generated by exothermic reactions and combustion.

In short, the MRU simultaneously reduces CO2 emissions and creates revenue streams with minimal capital expenditure.

For maximum efficiency, Well Power plans to provide its technology in conjunction with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Technical services will also be accompanied with consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

The MRU provides a solution to both sides of the spectrum. For the environment and local populations, reduced emissions and improved economic development; for oil producers, the opportunity to turn waste into revenue.

By eliminating legacy flaring and minimizing new flaring, Well Power is positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency.

For more information, visit www.wellpowerinc.com

Let us hear your thoughts: Well Power Inc. Message Board

According to analysis contained in a Q1 2015 report from investment banking firm, Capstone Partners, long known for their insights into M&A and capital markets, the $788.7 billion annual spend in K-12 education markets has become an easy target for disruptive educational technologies in recent years, as the industry moves increasingly to modernize via digital solutions that improve both overall systemic efficiencies, as well as student outcomes. A company like Sibling Group Holdings, Inc. (OTCQB: SIBE), which is leveraging an EdTech (education technology) roll-up strategy that spans eLearning and blended learning, as well as curriculum design and backend education, is poised to succeed mightily in this actively consolidating market.

The company’s momentum is due in large part to an already established and increasingly strong brand presence, their acquisitive nature and expansion of core offerings, as well as an appetite for providing comprehensive, soup-to-nuts solutions for both domestic and global education markets. Solutions which run the gamut from curriculum to course certification as no other player in the industry today. Ranging from tailored Common Core and iNACOL (International Association for K-12 Online Learning) compliant curricula for the domestic markets, complete with assessment and course certification, to ESL (English as a second language) minded and globally approachable frameworks. A growing emphasis on providing solutions for the broader, underserved, and highly lucrative international markets, will likely emerge as one of the company’s strongest selling points long-term.

Capstone’s Q1 report on the education market was particularly focused on M&A activity within the sector, making the case that the projected acceleration of such activity in coming years – driven in large part by attractive valuation multiples resident in buyout target technologies and capabilities that will help companies thrive as the industry rapidly evolves – was the strongest indicator of how factors like eLearning are revolutionizing the industry worldwide. Sibling Group’s Blended Schools Network (BSN) business unit (http://blendedschools.net) is a perfect example of transformative eLearning in this space, as it provides some 192 Common Core compatible master courses for K-12 and does so via a Learning Management Systems (LMS) that tracks student activity and results, while also providing a hosted environment that enables course authoring.

BSN features educational technology company Instructure’s cloud-native Canvas LMS, in addition to complete online Language Institute courses covering a wide variety of languages from Chinese to Latin, all of which are oriented along current ESL parameters. The BSN curriculum was recently certified in California according to the University of California’s A-G requirements (all subjects from History and Social Science “A” to College-prep and elective “G”), when Mountain House High School took their personalized learning initiative to the next level and worked with SIBE to create a BSN-based personalized learning environment. This was a huge win for SIBE, as California is the largest K-12 market in the country, with around $76.6 billion in total K-12 funding budgeted for this year, and General Fund resources of $109.4 billion.

One of the biggest changes in the industry is to the roughly $14 billion textbook market, which has historically been in the iron grip of a tiny handful of companies like Pearson and McGraw-Hill. This market is under immense pressure today from eLearning and the continuing shift to digital and open-access education formats, with increasingly popular educational alternatives like EdX, MIT OpenCourseware, and Coursera threatening to be the extinction level event that wipes out such dinosaur textbook companies. BLS data makes the case quite clear as to one major reason for the extinction of antiquated print textbooks, showing an 800 percent rise over the past three decades in the cost of such books, a rise outpacing the CPI by 550 percent, and even outpacing fast-rising medical services by as much as 225 percent.

Hence the ongoing arms race in eLearning, where companies like MOOC-focused (massive open online courses) Coursera have added a number of schools, courses and languages to their basket in recent years. Or companies like Chegg, Inc. (NYSE: CHGG), which used to focus on renting/selling textbooks, has executed a series of key acquisitions over a similar time span, with a decided emphasis on transitioning to an all-digital footprint. Chegg did a spate of acquisitions last year, spending a total of $57.7 million in cash and stock in order to pick up college coupon book mavens The Campus Special, online/on-demand video tutoring services provider InstaEDU, and internship marketplace interactive tools and services provider Internships, LLC.

In this light, SIBE’s acquisition of Urban Planet Mobile™ (UPM), a platform designed to teach people all over the world the English language, which caters specifically to mobile delivery, makes a great deal of sense. Especially considering Gilfus Education Group’s projections that the global K-12 education market will soar to $2.9 trillion by 2017, led by countries like China and India, as well as the GCC (the Persian Gulf states excluding Iraq), where TechNavio forecasts a CAGR of over 3 percent through 2019. UPM, via patent-pending design and delivery, makes lessons available on any mobile, not just the latest smartphones, making the platform ideal for countries like India, where mobile coverage far exceeds the coverage of ESL class availability.

SIBE’s recent announcement of a strategic partnership and $3.75 million funding arrangement with PRC-based international education management and consulting company, Shenzhen Times, which develops and sells everything from computer networks and software, to communications products, gives UPM access to a massive K-12 market worth well over $172 billion. A market which is projected to grow at a CAGR of 12 percent through 2018. With broad traction across not only the education market, but on into the healthcare and literacy markets, UPM has the potential to see a good deal of upside from SIBE’s expansion into China and the company is not intent to rest on their laurels here either. Sibling Group plans to expand further into the burgeoning global eLearning and mEducation markets, leveraging a host of compelling products and services.

Pure-cloud modular LMS developer Docebo recently forecast the self-paced global eLearning market alone as climbing to $51.5 billion by next year and the ongoing M&A activity within the EdTech sector is a clear indication of how hot the market is, and will likely remain for some time. TechNavio forecasts for the global eLearning market as growing at a CAGR of nearly 26 percent through 2018 and SIBE’s EdTech roll-up strategy, where they look to become one of the key players in the delivery and management of educational content, makes them an exciting landmark to check out amid the lush eLearning landscape. The company’s distinct advantage of being a single source vendor that can provide a complete, curriculum to course certification solution set, including the comprehensive course authoring tools and systems needed to help maximize student outcomes and better train educators, sets SIBE apart from the competition very clearly.

Take a closer look at SIBE by visiting www.siblinggroup.com

Let us hear your thoughts: Sibling Group Holdings, Inc., Message Board

International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies and biomedical products, this morning told investors that it has been chosen to deliver an oral presentation on its preclinical studies in Parkinson’s at the 21st annual meeting of the International Society for Cellular Therapy in Las Vegas. ISCO’s chief scientific officer, Ruslan Semechkin, Ph.D., will discuss the data at the “Regeneration and Nervous System Repair” session at 11:45 a.m. on May 30, 2015 in a presentation entitled “Human Parthenogenetic Derived Neural Stem Cells for the Treatment of Parkinson’s Disease.”

ISCO has built an extensive preclinical dataset from a series of GLP and non-GLP studies on human parthenogenetic neural stem cells (hpNSC). The dataset includes safety studies, where hpNSC were transplanted into the brains of healthy animals, and proof-of-principle studies where the cells were transplanted into animals with induced Parkinson’s disease symptoms. The studies show that hpNSCs are well tolerated with no evidence of tumor formation even at very high doses and have the ability to protect and recover neurons, increase dopamine levels and improve the motor function. The Company has submitted a CTX application to the Australian regulatory authorities and plans to begin the phase 1/2a clinical study in Parkinson’s disease within the next few months.

The International Society for Cellular Therapy (ISCT) is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. ISCT is one of the only organizations focused on pre-clinical and translational aspects of developing cell therapy products. As such, ISCT helps academic, government and biotech/pharma sectors transform research into practice and product. Over 1200 international delegates including clinicians, scientists and regulatory experts are expected to attend this year’s meeting.

For more information on ISCO and its hpNSCs, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

View Systems, a Baltimore manufacturer and leading provider of integrated weapons detection systems, announces that it has engaged the investor relations services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value.

“Efficient communication is a highly valued component of our business model in terms of how we relate to existing and potential shareholders,” stated View Systems’ CEO Gunther Than. “As we continue to evolve the View Systems’ brand, we aim to elevate our current communication initiatives to raise visibility of our brand and make sure investors are up-to-date with our operations, potential and achievements.”

QualityStocks will use its vast network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to enhance View Systems’ visibility and market recognition while creating a new dimension of communication and transparency between the Company and the investment community.

“View Systems is focused on expanding its technology and services to become a leading player in the $100 billion-a-year global security industry,” stated QualityStocks Managing Director Michael McCarthy. “Never before has global security been more important, and we’re excited to partner with an innovative security solutions provider like View Systems. Our goal is to make sure the investment community recognizes View Systems as a competitive and high-potential industry player.”

For more information, visit www.viewsystems.com

Let us hear your thoughts: View Systems, Inc. Message Board

Pure Hospitality Solutions announced that it is partnering with Investors Hangout to provide additional investor information to shareholders about the Company. Interested parties can visit the Investor board to engage in virtual conversation about Pure Hospitality solutions at http://investorshangout.com/Pure-Hospitality-Solutions-Inc-PNOW-65267.

Melvin Pereira, President and CEO of Pure Hospitality Solutions, Inc. commented, “With all of the ‘pump-and-dump’ and ‘bashing’ boards that exist out there, we are very pleased to partner with a platform that is in the midst of changing how these boards operate. Investors Hangout does not allow frivolous comments one way or the other; no excessive praising or bashing, just facts communicated by our Company or inquiries from shareholders/investors seeking additional information. From a programming perspective, this platform is top-notch… One can see that there is a true webmaster running the Company, not someone looking to extort money or information as other major platforms attempt to do.”

PNOW management has noted that their association with Investors Hangout is designed to offer an added alternative information source for current and perspective shareholders. “With all the progress we’re experiencing behind the scenes, we’re happy to have another distribution channel in which to post our information,” Pereira continued. “Not only will we have new eyes viewing our information, we now have a platform that we can upload our information to, aside from our website, which should continue to help steadily grow our investor base.”

Pure Hospitality Solutions views the Investors Hangout partnership as an effective way to present factual information. In summary, Pereira said, “There’s very little that annoys me more than people posting fake, misleading and deceptive information around the internet. We all know of the ‘hubs’ out there that have members constantly posting frivolous information in an attempt to bring down our value. We urge all our shareholders to break away from the typical hub and visit our Pure Hospitality Solutions page on Investors Hangout to ensure the information you’re reading is legitimate.”

PURE provides proprietary technology, marketing solutions and branding services to hotel operators and condominium owners. PURE looks to build operations in online marketing and hotel internet booking engine services, hotel branding and own, operate and occasionally develop, boutique hotels under the new, “by PURE” brand.

For more information on the company visit www.purenow.solutions

Let us hear your thoughts: Oriens Travel and Hotel Management Corp. Message Board

hopTo is providing a new standard in mobile productivity through the continued development of its hopTo workspace platform. The company’s proprietary system enables users to search, access, create, edit and share content directly from their mobile devices without compromising enterprise security by saving documents directly to a cloud drive or corporate network. Through its dedication to allowing production without boundaries, hopTo has established a presence on the leading edge of mobile development.

Mobile solutions for enterprise productivity have seen an explosion in overall popularity over recent years. According to digital advertising agency Vertic, an estimated 96.3 million enterprise tablets are expected to be shipped by 2016. When accounting for the presence of ‘bring your own device’ (BYOD) options at many companies, it’s clear to see that the market for mobile productivity solutions is both substantial and rapidly expanding.

Despite the natural evolution of companies toward mobile infrastructure, two major concerns have limited the market’s growth in previous years: cost and security. The hopTo Work mobile app addresses both of these concerns, giving hopTo a strong strategic edge as the market continues to mature.

To address cost concerns, the company’s platform leverages existing infrastructure. By allowing users to avoid the need for additional hardware or software, hopTo eliminates complicated installation processes and costly startup expenditures. In this way, the company gives its customers the means to increase employee productivity without burdening existing IT personnel. Additionally, the ability to control accessibility remotely ensures that corporate data is always secure. This allows organizations to utilize a BYOD approach to mobility without risking sensitive data in the event of a lost device or termination of employment.

In the first quarter of 2015, hopTo has experienced promising growth that should propel the company towards continued prosperity in the competitive industry. With revenue growth of approximately ten percent from the previous year and the formation of powerful strategic partnerships, hopTo is in a strong position moving forward.

“We are pleased with the momentum that is taking place with the demand for hopTo Work,” stated Eldad Eilam, President and Chief Executive Officer of hopTo. “Feedback from our customers, prospective customers and the customers of our channel partners is extremely positive and we are beginning to see acceptance in many large international markets as well as the U.S.”

On the heels of an announced distribution agreement with Adapt Software – a Microsoft Gold Certified Partner with over 1,200 clients, including GE, Samsung and Vodafone – hopTo is continuing to establish a powerful presence in the global mobile productivity market. As the company continues to refine and expand its product offerings, look for hopTo to realize significant growth opportunity in the years to come.

For more information, visit www.hopto.com

OncoSec Medical, Inc. is a biotechnology company pioneering new technologies designed to stimulate the body’s immune system to target and attack cancer. The company is currently conducting preclinical and clinical studies targeting various cancers using its proprietary investigational platform, ImmunoPulse™. Early study results have laid the groundwork for OncoSec’s eventual expansion into new DNA-encoded therapeutic candidates and tumor indications, which will allow the company to continue on its mission to harness the body’s immune system and take the fight against cancer directly to the tumor.

Based in San Diego, OncoSec currently has a promising clinical pipeline with four ongoing studies utilizing both monotherapy with the company’s ImmunoPulse™ IL-12 immunotherapy platform and specialized combination therapy. The company is currently proceeding with trials studying the safety and efficacy of its platform in treating multiple stages of metastatic melanoma, head and neck cancer, and triple negative breast cancer. These studies could prove to be monumental in the global battle against various forms of cancers, as illustrated by statistical data surrounding melanoma.

Despite accounting for less than two percent of skin cancer cases, melanoma causes a large majority of skin cancer deaths, according to the American Cancer Society. With diagnosis rates steadily increasing for more than three decades, the demand for improved treatment options is at an all-time high. In 2015, it’s estimated that over 73,000 new melanoma cases will be diagnosed and nearly 10,000 people are expected to die from the disease.

ImmunoPulse™ focuses on the delivery of DNA-based interleukin-12 (IL-12), which is a naturally occurring protein that’s been shown as effective in delivering immune-stimulating functions, directly to the tumor through a sequence of short electrical pulses. By establishing a localized presence of this powerful protein in the tumor microenvironment, the patient’s immune system learns to target and attack tumors throughout the body.

Early data from OncoSec’s trials is promising. The company’s multi-center Phase II trial recorded an overall response in nearly one-third of patients, with half of all patients showing complete regression in at least one untreated lesion. By reliably promoting regression in an untreated area, the company has a powerful proof of concept of the effectiveness of its immune system boosting platform.

Promising results have led to several significant collaborations throughout the biopharmaceutical industry for OncoSec. To date, the company is working with Merck, Heat Biologics, PerkinElmer and Plexxikon on clinical and preclinical collaborations to further study the effectiveness of its ImmunoPulse™ platform.

“With the support of our shareholders, we look forward to validating our ImmunoPulse™ technology in clinical and preclinical studies, generating more value for our investors, and securing our place in this long-awaited revolution in cancer treatment,” stated Punit Dhillon, Chief Executive Officer and President of OncoSec.

For more information, visit www.oncosec.com

An aging population is currently highlighting the considerable limitations of the medical industry. According to the Mayo Clinic, treatments are increasingly unable to keep pace with the needs of patients, with clinicians only having access to medications or devices that can manage symptoms. However, advances in developmental and cell biology, immunology and related fields have unlocked huge potential for the industry, and regenerative medicine looks to be the game-changing solution.

Despite its promise, regenerative medicine faces significant hurdles moving forward. In particular, immune rejection of transplanted cells has severely limited the huge potential of stem cell therapy. International Stem Cell Corporation (OTCQB: ISCO), through its powerful new stem cell technology, could be on the cusp of overcoming these limitations, opening the door for major advances in the medical market.

Parthenogenesis, ISCO’s proprietary stem cell development process, has allowed the company to develop a new class of stem cells, known as human parthenogenetic stem cells (hpSCs), which possess the most favorable characteristics of the existing classes. Through this technique, ISCO is able to create cells that are exactly matched or histocompatible with large segments of the human population, limiting the risk of immune rejection during treatment.

ISCO has made noteworthy strides towards the commercialization of its cell therapy treatment this year, capturing the attention of industry experts around the globe.

“In the first quarter of 2015 we completed all the necessary preclinical studies of our Parkinson’s program and formally submitted our application to begin the first clinical study of this novel approach to treating this debilitating disease in humans,” stated Andrey Semechkin, Ph.D., Chief Executive Officer and Co-Chairman of ISCO.

Highlights from the company’s business activity thus far in 2015 include the completion of preclinical studies and submission of an application to begin human trials in Australia, completion of manufacture of a bank of 2.6 billion human cells for use in clinical trials and the approval of a Japanese patent covering parthenogenetic methods of stem cell creation, meaning ISCO now has patent protection in all three major world markets (US, EU and Japan).

“We continue to expect to make significant progress during the rest of 2015 towards our goal of providing a viable treatment option for people with Parkinson’s disease,” continued Semechkin.

According to Florida Hospital, Parkinson’s disease affects up to one million people in the United States, with doctors diagnosing as many as 60,000 new cases each year. Upon completion of clinical trials, the potential market for ISCO’s parthenogenetic cell creation is effectively limitless. As the company continues towards marketization for the treatment of Parkinson’s disease, look for substantial opportunities for growth within the medical industry in the years to come.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board